EU-funded R&D project

Personalized Care for Patients with Advanced Chronic Diseases

Due to population ageing and advances in medical science, people with chronic diseases – including advanced severe life-threatening chronic diseases – live longer. Challenges are how to sustain quality independent living for the patient; support caregivers facing an increasing burden; create sustainable healthcare and social care systems with limited resources. 

ADLIFE aims to provide a solution for the integration of therapies and approaches targeting early detection and assessment of deterioration, advanced and well-coordinated care planning and integrated supportive care to enhance quality of life, reduce suffering and accelerate recovery for these patients and their families. It will deploy developed and validated personalised digital solutions for integrated supportive care based on H2020 projects C3-Cloud and Power2DM, previously tested in two health systems. The ADLIFE Toolbox solutions include: a Personalised Care Plan Management Platform, Clinical Decision Support Services; Interoperability Solutions and Patient Empowerment Platform with Just-In Time Adaptive Intervention Delivery Engine.

i~HD is a partner and leads work on data management and GDPR compliance, the communication of the project results to patients, the public and to healthcare systems, and contributes to the business plans for sustainability.

The ADLIFE Project has received funding from the European Union under the Horizon 2020 Programme, and started on 1 January 2020.

Consortium Partners

Asociación Centro de Excelencia Internacional en Investigación sobre Cronicidad (KRONIKGUNE), University of Strathclyde, The University of Warwick, Odense University Hospital, Falkiewicz Specialist Hospital, OptiMedis, Region Jämtland Härjedalen, Assuta Ashdod Hospital, Software Research & Development Consultancy (SRDC), EVERIS, i~HD, Osakidetza, Maccabi Healthcare Services

Supported by